F-FDG PET as an Early Response Parameter in Stereotactic Body Radiotherapy for stage I-II (T1-T3, N0) Non Small Cell Lung Carcinoma: A Pilot Study

F-FDG PET as an Early Response Parameter in Stereotactic Body Radiotherapy for stage I-II (T1-T3, N0) Non Small Cell Lung Carcinoma: A Pilot Study - RT2007-04

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32072

Enrollment

Registered

2008-01-18

Start date

2007-12-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non small cell lung carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: T1-T3, N0, M0 Adequate pulmonary function Medically inoperable or refused surgery Life expectancy of at least 6 months Histological conformation of non-small cell lung cancer or a F-FDG positive, growing mass on CT-thorax, suggestive of NSCLC

Exclusion criteria

Exclusion criteria: Disease other than T1-T3, N0 M0 Inadequate pulmonary function Life expectancy less than 6 months

Design outcomes

Primary

Measure	Time frame
1. The metabolic response after the first fraction	—

Secondary

Measure	Time frame
1. The metabolic response 12 weeks after completion of SBRT 2. The intra-individual dynamics between these scans 3. Tumor response on CT-thorax according to RECIST-criteria 12 weeks after completion of SBRT	—

Countries

Netherlands

Outcome results